583 related articles for article (PubMed ID: 23507917)
1. Recent advances in the treatment of hepatocellular carcinoma.
Padhya KT; Marrero JA; Singal AG
Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the treatment of hepatocellular carcinoma.
Singal AG; Marrero JA
Curr Opin Gastroenterol; 2010 May; 26(3):189-95. PubMed ID: 20224395
[TBL] [Abstract][Full Text] [Related]
3. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
[TBL] [Abstract][Full Text] [Related]
5. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
Choi JY
Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatocellular carcinoma.
Blum HE
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
8. Current approach to hepatocellular carcinoma.
Abrams P; Marsh JW
Surg Clin North Am; 2010 Aug; 90(4):803-16. PubMed ID: 20637949
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: current management and recent advances.
Lau WY; Lai EC
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):237-57. PubMed ID: 18522878
[TBL] [Abstract][Full Text] [Related]
10. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
11. Downstaging hepatocellular carcinoma prior to liver transplantation.
Gamblin TC; Geller DA
Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
[No Abstract] [Full Text] [Related]
12. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the treatment response of HCC.
Kim KW; Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: an update.
Blum HE; Spangenberg HC
Arch Iran Med; 2007 Jul; 10(3):361-71. PubMed ID: 17604475
[TBL] [Abstract][Full Text] [Related]
15. Chemoembolization and bland embolization: a critical appraisal.
Befeler AS
Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatocellular carcinoma.
Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
[TBL] [Abstract][Full Text] [Related]
17. Established and emerging therapies for hepatocellular carcinoma.
Cicinnati VR; Sotiropoulos GC; Beckebaum S
Minerva Med; 2010 Dec; 101(6):405-18. PubMed ID: 21196900
[TBL] [Abstract][Full Text] [Related]
18. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
Lao OB; Weissman J; Perkins JD
Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Cescon M; Cucchetti A; Ravaioli M; Pinna AD
J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
[TBL] [Abstract][Full Text] [Related]
20. [Hepatocellular carcinoma].
Semela D; Heim M
Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
